Literature DB >> 17993993

Strenuous exercise-induced alterations of muscle fiber cross-sectional area and fiber-type distribution in steroid myopathy rats.

Ken Uchikawa1, Hidetoshi Takahashi, Kimitaka Hase, Yoshihisa Masakado, Meigen Liu.   

Abstract

OBJECTIVE: To investigate the effect of exercise intensity on the muscle histopathology in steroid myopathy rats.
DESIGN: Eight-week-old male Wistar rats (n=40) were divided into four groups: a control group (n=4), steroid-only group (n=12), moderate exercise + steroid group (n=12), and a high-intensity exercise + steroid group (n=12). Five weeks after triamcinolone injection, the soleus muscle (SOL) and extensor digitorum longus muscle (EDL) were removed and stained for adenosine triphosphatase (ATPase). The muscle fiber area and fiber type distribution of each fiber type were measured.
RESULTS: In the high-intensity exercise group, the type I fibers in the SOL and the type IIb fibers in the EDL showed significant atrophy. In the fiber distribution of the SOL, type I fibers decreased in the steroid-only group and high-intensity exercise group as compared with the control, whereas there was a significant increase in the moderate exercise group vs. the steroid-only group. In the EDL, type I fibers were significantly greater in the moderate- and high-intensity exercise groups, whereas type IIb fibers significantly decreased in the moderate-exercise group as compared with the steroid-only group.
CONCLUSIONS: In rats with steroid myopathy, high-intensity exercise caused changes such as muscle atrophy. The fiber type distribution of the SOL changed from type II fibers to type I fibers in the moderate exercise group. Intensive exercise, however, resulted in transformation from type I to type II in the fiber type distribution. For the EDL, no significant fiber type changes were observed with high-intensity exercise when compared with moderate exercise.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17993993     DOI: 10.1097/PHM.0b013e31815869d0

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  7 in total

Review 1.  Steroid myopathy: some unresolved issues.

Authors:  M A Minetto; F Lanfranco; G Motta; S Allasia; E Arvat; G D'Antona
Journal:  J Endocrinol Invest       Date:  2011-05       Impact factor: 4.256

2.  REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade.

Authors:  Rashmi Kumari; Lisa B Willing; Leonard S Jefferson; Ian A Simpson; Scot R Kimball
Journal:  Biochem Biophys Res Commun       Date:  2011-08-11       Impact factor: 3.575

Review 3.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

4.  Effects of exercise in patients with connective tissue disease receiving high-dose glucocorticoids: A pilot prospective cohort study.

Authors:  Masaaki Nagashima; Daiki Takahashi; Takashi Mizushima; Katsuya Yamauchi
Journal:  Eur J Appl Physiol       Date:  2021-04-29       Impact factor: 3.078

5.  Effectiveness and Safety of Rehabilitation for Pediatric Patients with Nephrotic Syndrome in the Acute Phase: A Case Study.

Authors:  Aki Tabata; Hiroki Yabe; Yuya Mitake; Tomohiro Shirai; Marina Yoshida; Rie Kurosu; Ken Kawamura
Journal:  Prog Rehabil Med       Date:  2022-08-10

6.  An unusual case of shortness of breath.

Authors:  S F Wan Muhammad Hatta; L Kandaswamy; C Gherman-Ciolac; J Mann; H N Buch
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-07-26

7.  Persisting Muscle Dysfunction in Cushing's Syndrome Despite Biochemical Remission.

Authors:  Frederick Vogel; Leah T Braun; German Rubinstein; Stephanie Zopp; Heike Künzel; Finn Strasding; Adriana Albani; Anna Riester; Ralf Schmidmaier; Martin Bidlingmaier; Marcus Quinkler; Timo Deutschbein; Felix Beuschlein; Martin Reincke
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.